Hepion Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 04:12 pm EDT
Hepion Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 14.08 million compared to USD 19.91 million a year ago. Basic loss per share from continuing operations was USD 3.68 compared to USD 5.22 a year ago.
For the six months, net loss was USD 27.34 million compared to USD 26.84 million a year ago. Basic loss per share from continuing operations was USD 7.16 compared to USD 7.04 a year ago.